• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
miR-381-3p suppresses the proliferation of oral squamous cell carcinoma cells by directly targeting FGFR2.微小RNA-381-3p通过直接靶向成纤维细胞生长因子受体2抑制口腔鳞状细胞癌细胞的增殖。
Am J Cancer Res. 2017 Apr 1;7(4):913-922. eCollection 2017.
2
MicroRNA-342-3p functions as a tumor suppressor by targeting LIM and SH3 protein 1 in oral squamous cell carcinoma.微小RNA-342-3p通过靶向口腔鳞状细胞癌中的LIM和SH3结构域蛋白1发挥抑癌作用。
Oncol Lett. 2019 Jan;17(1):688-696. doi: 10.3892/ol.2018.9637. Epub 2018 Oct 29.
3
miR-23a-3p suppresses cell proliferation in oral squamous cell carcinomas by targeting FGF2 and correlates with a better prognosis: miR-23a-3p inhibits OSCC growth by targeting FGF2.miR-23a-3p 通过靶向 FGF2 抑制口腔鳞状细胞癌的细胞增殖,且与较好的预后相关:miR-23a-3p 通过靶向 FGF2 抑制口腔鳞状细胞癌的生长。
Pathol Res Pract. 2019 Apr;215(4):660-667. doi: 10.1016/j.prp.2018.12.021. Epub 2018 Dec 24.
4
FGFR2 and miR-889-3p expression in oral cancer is associated with cervical lymph node metastasis.口腔癌中FGFR2和miR-889-3p的表达与颈部淋巴结转移相关。
Oral Dis. 2024 Nov;30(8):4838-4846. doi: 10.1111/odi.14933. Epub 2024 Mar 15.
5
MiR-376c-3p regulates the proliferation, invasion, migration, cell cycle and apoptosis of human oral squamous cancer cells by suppressing HOXB7.微小RNA-376c-3p通过抑制HOXB7调控人口腔鳞状癌细胞的增殖、侵袭、迁移、细胞周期及凋亡。
Biomed Pharmacother. 2017 Jul;91:517-525. doi: 10.1016/j.biopha.2017.04.050. Epub 2017 May 5.
6
Inhibition of miR-103a-3p suppresses the proliferation in oral squamous cell carcinoma cells via targeting RCAN1.miR-103a-3p 的抑制通过靶向 RCAN1 抑制口腔鳞状细胞癌细胞的增殖。
Neoplasma. 2020 May;67(3):461-472. doi: 10.4149/neo_2020_190430N382. Epub 2020 Feb 28.
7
MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1.MicroRNA-486-3p 通过靶向 DDR1 发挥抑癌作用,抑制口腔癌的发生。
J Exp Clin Cancer Res. 2019 Jun 28;38(1):281. doi: 10.1186/s13046-019-1283-z.
8
LncRNA MEG3 suppresses migration and promotes apoptosis by sponging miR-548d-3p to modulate JAK-STAT pathway in oral squamous cell carcinoma.长链非编码 RNA MEG3 通过海绵吸附 miR-548d-3p 抑制口腔鳞状细胞癌细胞迁移并促进细胞凋亡,从而调节 JAK-STAT 通路。
IUBMB Life. 2019 Jul;71(7):882-890. doi: 10.1002/iub.2012. Epub 2019 Feb 26.
9
LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.长链非编码 RNA HOXA11-AS 通过抑制 miR-214-3p 的表达促进口腔鳞状细胞癌的增殖和顺铂耐药性。
Biomed Res Int. 2019 May 28;2019:8645153. doi: 10.1155/2019/8645153. eCollection 2019.
10
miR-338-3p acts as a tumor suppressor in lung squamous cell carcinoma by targeting .miR-338-3p通过靶向……在肺鳞状细胞癌中发挥肿瘤抑制作用。
Cancer Pathog Ther. 2022 Dec 28;1(2):87-97. doi: 10.1016/j.cpt.2022.12.004. eCollection 2023 Apr.

引用本文的文献

1
DLK1-DIO3 region as a source of tumor suppressor miRNAs in papillary thyroid carcinoma.DLK1-DIO3区域作为甲状腺乳头状癌中肿瘤抑制性微小RNA的来源
Transl Oncol. 2024 Aug;46:101849. doi: 10.1016/j.tranon.2023.101849. Epub 2024 May 31.
2
UBE2C: A pan-cancer diagnostic and prognostic biomarker revealed through bioinformatics analysis.UBE2C:通过生物信息学分析发现的一种泛癌诊断和预后生物标志物。
Cancer Rep (Hoboken). 2024 Apr;7(4):e2032. doi: 10.1002/cnr2.2032.
3
miR-381 Inhibits Proliferation and Invasion of Non-Small-Cell Cancer Cells by Targeting USP39.miR-381 通过靶向 USP39 抑制非小细胞癌细胞的增殖和侵袭。
Dis Markers. 2022 Aug 21;2022:2195393. doi: 10.1155/2022/2195393. eCollection 2022.
4
Pan-cancer analysis of microRNA expression profiles highlights microRNAs enriched in normal body cells as effective suppressors of multiple tumor types: A study based on TCGA database.基于 TCGA 数据库的泛癌分析 miRNA 表达谱研究提示,正常体细胞中富含的 miRNA 作为多种肿瘤类型的有效抑制物。
PLoS One. 2022 Apr 27;17(4):e0267291. doi: 10.1371/journal.pone.0267291. eCollection 2022.
5
Long non-coding RNA FLVCR1-AS1 functions as a ceRNA to aggravate cervical cancer cell growth by the miR-381-3p/MAGT1 axis.长链非编码 RNA FLVCR1-AS1 通过 miR-381-3p/MAGT1 轴作为 ceRNA 加重宫颈癌细胞生长。
Arch Gynecol Obstet. 2022 Dec;306(6):2093-2103. doi: 10.1007/s00404-022-06468-6. Epub 2022 Apr 16.
6
Overexpression of microRNA-381-3p ameliorates hypoxia/ischemia-induced neuronal damage and microglial inflammation via regulating the C-C chemokine receptor type 2 /nuclear transcription factor-kappa B axis.过表达 microRNA-381-3p 通过调节 C-C 趋化因子受体 2 / 核转录因子-κB 轴减轻缺氧/缺血诱导的神经元损伤和小胶质细胞炎症。
Bioengineered. 2022 Mar;13(3):6839-6855. doi: 10.1080/21655979.2022.2038448.
7
CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.CPNE1是一种潜在的预后生物标志物,与免疫浸润相关,并促进肝细胞癌的进展。
Cancer Cell Int. 2022 Feb 9;22(1):67. doi: 10.1186/s12935-022-02485-2.
8
MicroRNA-381 in human cancer: Its involvement in tumour biology and clinical applications potential.微小 RNA-381 在人类癌症中的作用:其在肿瘤生物学和临床应用潜力中的参与。
J Cell Mol Med. 2022 Feb;26(4):977-989. doi: 10.1111/jcmm.17161. Epub 2022 Jan 11.
9
miR-381-3p Involves in Glioma Progression by Suppressing Tumor-Promoter Factor ANTXR1.miR-381-3p 通过抑制肿瘤促进因子 ANTXR1 参与胶质瘤的进展。
Comput Math Methods Med. 2021 Dec 16;2021:4883509. doi: 10.1155/2021/4883509. eCollection 2021.
10
NRP2, a potential biomarker for oral squamous cell carcinoma.NRP2,一种口腔鳞状细胞癌的潜在生物标志物。
Am J Transl Res. 2021 Aug 15;13(8):8938-8951. eCollection 2021.

本文引用的文献

1
Low expression of miR-381 is a favorite prognosis factor and enhances the chemosensitivity of osteosarcoma.miR-381的低表达是一个良好的预后因素,并增强骨肉瘤的化疗敏感性。
Oncotarget. 2016 Oct 18;7(42):68585-68596. doi: 10.18632/oncotarget.11861.
2
MiR-497 enhances metastasis of oral squamous cell carcinoma through SMAD7 suppression.微小RNA-497通过抑制SMAD7增强口腔鳞状细胞癌的转移。
Am J Transl Res. 2016 Jul 15;8(7):3023-31. eCollection 2016.
3
FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma.FGFR2过表达可预测转移性乳头状肾细胞癌患者的生存结局。
Clin Transl Oncol. 2017 Feb;19(2):265-268. doi: 10.1007/s12094-016-1524-y. Epub 2016 Jul 5.
4
miR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2.微小RNA-494通过靶向成纤维细胞生长因子受体2抑制卵巢癌细胞增殖并促进其凋亡。
Oncol Lett. 2016 Jun;11(6):4245-4251. doi: 10.3892/ol.2016.4527. Epub 2016 May 5.
5
MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1.微小RNA-381通过靶向Twist1在结直肠癌中发挥肿瘤抑制作用。
Onco Targets Ther. 2016 Mar 7;9:1231-9. doi: 10.2147/OTT.S99228. eCollection 2016.
6
Fibroblast growth factor receptor 2 expression, but not its genetic amplification, is associated with tumor growth and worse survival in esophagogastric junction adenocarcinoma.成纤维细胞生长因子受体2的表达而非其基因扩增,与食管胃交界腺癌的肿瘤生长及较差的生存率相关。
Oncotarget. 2016 Apr 12;7(15):19748-61. doi: 10.18632/oncotarget.7782.
7
MiR-381 inhibits epithelial ovarian cancer malignancy via YY1 suppression.微小RNA-381通过抑制YY1抑制上皮性卵巢癌的恶性程度。
Tumour Biol. 2016 Jul;37(7):9157-67. doi: 10.1007/s13277-016-4805-8. Epub 2016 Jan 14.
8
MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma.微小RNA-381通过靶向肝细胞癌中的肝受体同源物-1抑制细胞生长和侵袭。
Oncol Rep. 2016 Mar;35(3):1831-40. doi: 10.3892/or.2015.4491. Epub 2015 Dec 16.
9
Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.大豆苷元是一种新型成纤维细胞生长因子受体2(FGFR2)抑制剂,在临床前模型中能有效抑制血管生成和肿瘤生长。
Oncotarget. 2015 Dec 29;6(42):44563-78. doi: 10.18632/oncotarget.6310.
10
Down-regulation of MicroRNA-381 promotes cell proliferation and invasion in colon cancer through up-regulation of LRH-1.下调 microRNA-381 通过上调 LRH-1 促进结肠癌细胞增殖和侵袭。
Biomed Pharmacother. 2015 Oct;75:137-41. doi: 10.1016/j.biopha.2015.07.020. Epub 2015 Aug 28.

微小RNA-381-3p通过直接靶向成纤维细胞生长因子受体2抑制口腔鳞状细胞癌细胞的增殖。

miR-381-3p suppresses the proliferation of oral squamous cell carcinoma cells by directly targeting FGFR2.

作者信息

Yang Xiao, Ruan Huibing, Hu Xi, Cao Anyi, Song Li

机构信息

Department of Stomatology, The Second Affiliated Hospital of Nanchang UniversityNanchang, Jiangxi, China.

Department of Orthopaedic Surgery, The Second Affiliated Hospital of Nanchang UniversityNanchang, Jiangxi, China.

出版信息

Am J Cancer Res. 2017 Apr 1;7(4):913-922. eCollection 2017.

PMID:28469963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5411798/
Abstract

Mutiple microRNAs are implicated in oral squamous cell carcinoma (OSCC), which is characterized by a high rate of proliferation and nodal metastasis. Data from the present study showed that miR-381-3p is significantly underexpressed in both OSCC tissues and cell lines. Overexpression of miR-381-3p led to marked suppression of proliferation and cell cycle progression of OSCC cells and promotion of apoptosis. Notably, fibroblast growth factor receptor 2 (FGFR2) was downregulated by miR-381-3p through direct interactions with its 3' untranslated region. Knockdown of FGFR2 recapitulated the growth suppressive effect of miR-381-3p. Conversely, restoring FGFR2 expression attenuated miR-381-3p-induced effects in OSCC cells. Expression patterns of miR-381-3p and FGFR2 were inversely correlated in OSCC tissues. Our collective results provide novel evidence that miR-381-3p acts as a tumor suppressor in OSCC by directly targeting FGFR2, thereby presenting a promising therapeutic target.

摘要

多种微小RNA与口腔鳞状细胞癌(OSCC)有关,其特征是增殖率高和淋巴结转移率高。本研究数据表明,miR-381-3p在OSCC组织和细胞系中均显著低表达。miR-381-3p的过表达导致OSCC细胞的增殖和细胞周期进程受到明显抑制,并促进细胞凋亡。值得注意的是,成纤维细胞生长因子受体2(FGFR2)通过与其3'非翻译区直接相互作用而被miR-381-3p下调。敲低FGFR2可重现miR-381-3p的生长抑制作用。相反,恢复FGFR2表达可减弱miR-381-3p在OSCC细胞中诱导的效应。在OSCC组织中,miR-381-3p和FGFR2的表达模式呈负相关。我们的综合结果提供了新的证据,表明miR-381-3p通过直接靶向FGFR2在OSCC中发挥肿瘤抑制作用,从而呈现出一个有前景的治疗靶点。